CAMP4 Therapeutics Corporation Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
CAMP4 Therapeutics Corporation (CAMP) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-13
- CAMP4 Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $0.00.
- CAMP4 Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $0.00.
- CAMP4 Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $0.00.
- CAMP4 Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was $0.00.
- CAMP4 Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $0.00.
- CAMP4 Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $0.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |